期刊文献+

基于Beers标准及疾病指南评价老年住院患者抗凝药物潜在性不适当用药 被引量:8

Evaluation of Potentially Inappropriate Use of Anticoagulant Drugs in Elderly Inpatients based on Beers Criteria and Disease Guidelines
在线阅读 下载PDF
导出
摘要 目的评价老年住院患者抗凝药物潜在不适当用药(PIM)情况。方法采用系统抽样法,收集2016年新疆医科大学附属中医医院年龄≥65岁同时使用抗凝药物的住院患者192例,基于2015版Beers标准老年患者基于肾功能尽可能避免或减少剂量的非感染药物种类及建议、药品说明书及抗凝治疗、预防深静脉血栓(DVT)等指南中推荐的给药方法,结合医院抗凝药物目录(依诺肝素注射液和利伐沙班片,不包括华法林),整理适合住院老年患者抗凝治疗PIM评价的标准,评价PIM发生情况。结果 192例患者中,PIM发生率为43.8%(84/192)。使用利伐沙班40例,PIM发生率为20.0%(8/40);使用依诺肝素152例,PIM发生率为50.0%(76/152)。发生PIM患者中,内科预防DVT 30例(35.7%),急性冠脉综合征(ACS)抗凝治疗21例(25.0%),骨科术后预防DVT 10例(11.9%),心房纤颤抗凝治疗8例(9.5%),其他抗凝指征15例(17.9%);主要表现为疗程不足(31例,36.9%)、剂量不足(20例,23.8%)、基于肾功能尽可能避免或减少剂量(17例,20.2%)、其他不合理原因(16例,19.1%)。结论老年住院患者抗凝药物使用存在PIM情况,应采取综合措施预防不合理用药。 Objective This study aimed to evaluate the potentially inappropriate use of anticoagulant drugs in elderly inpatients.Methods Using systematic sampling,we selected 192 elderly inpatients(≥65 years)receiving anticoagulant therapy in Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University in 2016.We developed potentially inappropriate medication(PIM)evaluation criteria for anticoagulation therapy in older adults based on the review of the lists and recommended administration methods of non-anti-infective drugs in 2015 American Geriatrics Society Beers Criteria that should be avoided or have their dose adjusted in accordance with the individual's kidney function,drug package inserts,methods of administration proposed in the guidelines for anticoagulation and deep vein thrombosis(DVT)prophylaxis,and the list of anticoagulation drugs for hospitals(enoxaparin injection and rivaroxaban tablets,not including warfarin),and used this criteria to assess the incidence of PIM in these participants.Results Among the 192 patients,the incidence of PIM was 43.8%(84/192).Specifically,the incidence of PIM among the 40 patients using rivaroxaban and 152 using enoxaprin was 20.0%(8/40)and 50.0%(76/152),respectively.The PIM cases included deep venous thrombosis(DVT)prevention(n=30,35.7%),acute coronary syndrome anticoagulant therapy(n=21,25.0%),DVT prevention after orthopedic surgery(n=10,11.9%),anticoagulation therapy for atrial fibrillation(n=8,9.5%),and other indications for anticoagulation(n=15,17.9%).The inappropriate use of medications mainly included insufficient duration of anticoagulant therapy(n=31,36.9%),insufficient dose of anticoagulants(n=20,23.8%),avoiding or reducing the dosage due to renal function(n=17,20.2%),and other inappropriate usage(n=16,19.1%).Conclusion Anticoagulant drug use in elderly inpatients frequently departs from professional recommendations and guidelines,thus comprehensive measures should be taken to prevent the inappropriate use of drugs.
作者 范芳芳 胡兰 姜倩 郑丽丽 姚莉 FAN Fang-fang;HU Lan;JIANG Qian;ZHENG Li-li;YAO Li(Department of Pharmacy,Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University,Urumqi 830000,China)
出处 《中国全科医学》 CAS 北大核心 2018年第5期566-570,共5页 Chinese General Practice
基金 新疆医科大学科研创新基金(XYDCX201605)
关键词 抗凝药 Beers标准 潜在性不适当用药 Anticoagulants Beers criteria Potentially inappropriate medication
作者简介 通信作者:姚莉,副主任药师,研究方向:临床药学;E-mail:10484624@qq.com
  • 相关文献

参考文献15

二级参考文献110

  • 1尹知训,余楠生,卢伟杰,李之琛,吴焯鹏,李建赤.初始全髋关节置换术静脉血栓栓塞症预防的临床研究[J].中国骨与关节外科,2013,6(S1):57-60. 被引量:19
  • 2邱贵兴,杨庆铭,余楠生,翁习生,王凯,李晓林.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究[J].中华骨科杂志,2006,26(12):819-822. 被引量:431
  • 3陈东峰,余楠生,卢伟杰,白波.低分子肝素联合间歇充气加压预防人工关节置换术后下肢深静脉血栓形成[J].中华骨科杂志,2006,26(12):823-826. 被引量:99
  • 4Geerts WH,Bergqvist D,Pineo GF,et al.Prevention of venous thromboembolism:American college of chest physicians Evidence-Based clinical practice guidelines (8th Edition)[J].Chest,2008,133(6 Suppl):381S-453S.
  • 5全国老龄工作委员会办公室.中国人口老龄化发展趋势预测研究报告[EB/OL].[2006-02-24].http://www.xinhuanet.com/newscenter/.
  • 6骨关节炎诊治指南(2007年版)[J].中华骨科杂志,2007,27(10):793-796. 被引量:2006
  • 7Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thrombo- embolism: the Seventh ACCP Conference on Antithrombotie and Thrombolytic Therapy [ J 1. Chest, 2004,126 ( 3 Suppl) : $338-400.
  • 8Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophy- laxis against venous thromboembolism 'after total hip or knee replace- ment : ameta-analysis of the randomized trials [ J ]. Lancet, 2001,358 : 9-15.
  • 9Comp PC, Spiro TE, Friedman R J, et al. Prolonged enoxaparin therapyto prevent venous thromboembolism after primary hip or knee replace- ment[ J]. J Bone JointSurg( Am ) , 2001,83:336-345.
  • 10Torbicki A, van Beek E JR, Charbonnier G, et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J, 2000, 21: 1301-1336.

共引文献541

同被引文献89

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部